Literature DB >> 20035256

MR imaging - an unreliable and potentially misleading diagnostic modality in patients with intracerebral calcium depositions. Case report.

Dusko Kozic1, Ljiljana Todorovic-Djilas, Robert Semnic, Ivana Miucin-Vukadinovic, Milos Lucic.   

Abstract

BACKGROUND: Since magnetic resonance imaging (MRI) is a method of choice for establishing the correct diagnosis in a great majority of neurologic disorders, especially in detection the causes of seizures and both acute and slowly progressive neurologic disturbances, computerized tomography is becoming more frequently excluded from obligate spectrum of diagnostic protocol.
METHODS: MRI was performed on 1.5 T MR scanner in two patients, in one suffering from pseudohypoparathyroidism, and in another with Fahr disease, while CT was initially excluded from the diagnostic protocol. In third patient, 11-year-old boy with hypercalcemia, both CT and MRI were indicated because of seizure attack.
RESULTS: Completely normal appearing brain parenchyma was seen on T2W images in a patient with clinical diagnosis of pseudohypoparathyroidism while extensive intracerebral calcifications were noted after additionally performed computerized tomography of the brain. In another patient with Fahr disease and neurologic symptoms, extensive calcifications were evident on CT, while MR examination had revealed bilateral symmetric lesions of prolonged T2W signal in the basal ganglia, supratentorial white matter and cerebellum, most compatible toxic/metabolic demyelination. In the third patient, a boy with hypercalcemia, marked left parietal cortical calcification was noted on CT, while MRI, including T2 gradient-echo sequence was inconclusive.
CONCLUSIONS: MRI, without CT, can be not only confusing, but even misleading diagnostic modality for detection of not only subtle, but also extensive cerebral calcifications. The benefit of gradient-echo T2 sequence, that is usually included in MR protocol when intracranial calcifications are suspected, is also rather limited.

Entities:  

Mesh:

Year:  2009        PMID: 20035256

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  7 in total

1.  Intracranial physiological calcifications evaluated with cone beam CT.

Authors:  P P Sedghizadeh; M Nguyen; R Enciso
Journal:  Dentomaxillofac Radiol       Date:  2012-07-27       Impact factor: 2.419

Review 2.  MR anatomy of deep brain nuclei with special reference to specific diseases and deep brain stimulation localization.

Authors:  Ryan Telford; Surjith Vattoth
Journal:  Neuroradiol J       Date:  2014-02-24

3.  Fahr disease: use of susceptibility-weighted imaging for diagnostic dilemma with magnetic resonance imaging.

Authors:  Neslin Sahin; Aynur Solak; Berhan Genc; Ugur Kulu
Journal:  Quant Imaging Med Surg       Date:  2015-08

Review 4.  From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders.

Authors:  Eva Yg De Vilder; Olivier M Vanakker
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

Review 5.  Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.

Authors:  Yi Wang; Tian Liu
Journal:  Magn Reson Med       Date:  2014-07-17       Impact factor: 4.668

6.  Brain calcifications and PCDH12 variants.

Authors:  Gaël Nicolas; Monica Sanchez-Contreras; Eliana Marisa Ramos; Roberta R Lemos; Joana Ferreira; Denis Moura; Maria J Sobrido; Anne-Claire Richard; Alma Rosa Lopez; Andrea Legati; Jean-François Deleuze; Anne Boland; Olivier Quenez; Pierre Krystkowiak; Pascal Favrole; Daniel H Geschwind; Adi Aran; Reeval Segel; Ephrat Levy-Lahad; Dennis W Dickson; Giovanni Coppola; Rosa Rademakers; João R M de Oliveira
Journal:  Neurol Genet       Date:  2017-07-26

Review 7.  Fahr Syndrome - an Important Piece of a Puzzle in the Differential Diagnosis of Many Diseases.

Authors:  Krzysztof Jaworski; Maria Styczyńska; Monika Mandecka; Jerzy Walecki; Dariusz A Kosior
Journal:  Pol J Radiol       Date:  2017-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.